On October 2, GNYHA will host a meeting at which the New York State Department of Health (DOH) and the Centers for Medicare & Medicaid Services (CMS) will review revised guidance in CMS’s State Operations Manual Appendix Q about what constitutes an immediate jeopardy (IJ) situation in a health care organization. This meeting was originally…

Dr. Molly Finnerty, Director of the Bureau of Evidence Based Services and Implementation Science in the New York State Office of Mental Health reviewed the new Substance Use Disorders Quality Indicator Set recently added to the Psychiatric Services and Clinical Knowledge Enhancement System (PSYCKES). PSYCKES is a HIPAA-compliant, web-based portfolio of tools designed to support…

We recognize that emergency departments (ED) play a critical role in addressing the national opioid crisis. Dr. Gail D’Onofrio, MD, MS, from the Department of Emergency Medicine at the Yale School of Medicine, a leading researcher in the treatment of patients with opioid use disorder in the ED, detailed clinical trial evidence and her experience…

In this webinar, attendees were reminded of policies prohibiting prior authorization for prescription for preferred or formulary forms of buprenorphine or injectable naltrexone for detoxification and maintenance of Opioid Use Disorder. Certified Recovery Peer Advocates, Jennifer Brock and Amory Mowrey, from the SHERPA program discussed SHERPA’s Peer Recovery Advocate services and shared the value of…

Updates on items enacted in the budget impacting efforts to address the opioid crisis were shared, data collection tool and process were reviewed, and participating hospitals shared their initiatives’ progress. Others were encouraged to prepare and ask any questions and share lessons learned.